Wuhan Newcando Biotechnology Co.,Ltd. was founded in 2013, and is located in the National Bio industry base, Optics Valley biological city, Wuhan. It is a high-tech enterprise focusing on Optoelectronics and biotechnology. The company is mainly engaged in the research and development of intelligent fluorescence immunity analyzer, myocardial infarction series detection reagent, on-line Fourier infrared spectrometer and other products and production and sales, the main business for the development of intelligent fluorescence immunoassay analyzer and reagent, providing intelligent immune analyzer, infrared spectrometer software products and services. The main service for bio medicine, bio energy, bio environmental control industry, especially in the bio environmental bioremediation industry has a wide range of users, customers have Beijing chinainvent Instrument Technology Co Ltd, East China University of Science and Technology national biochemical engineering technology research center.
In recent two years, the company has developed series of high-tech products around photoelectric technology, life science and computer technology, and has developed intelligent quantitative fluorescence immunoassay analyzer, myocardial infarction, heart failure detection reagent, online Fourier infrared spectrometer and other products. The product has the advantages of simple operation, stable performance, accurate, high intelligent degree, 10 minutes can obtain test results, not only suitable for large and medium-sized hospital for suspected myocardial infarction patients bedside rapid diagnosis of myocardial infarction, heart failure, and is also suitable for patient treatment monitoring, more suitable for primary hospitals for patients with chest pain timely diagnosis, can effectively improve the myocardial infarction diagnosis efficiency, improve the cure rate and reduce mortality.
